Patient-Derived Tumor Spheroids to Model the Tumor Microenvironment & Accelerate Drug Development
Time: 9:30 am
day: Day 1 AM
Details:
- Applying patient-derived tumor spheroids to model the tumor immune microenvironment including T cell infiltration and function, tumor fibrosis, CAF and endothelial cell biology
- Modeling the specific treatment response of compounds on the patient tumor immune environment and cancer epithelial cells using single cell RNASeq and proteomics
- Understanding how patient-derived tumor spheroids accelerate drug development using liver and pancreatic cancer as examples
